The Enterprise Value as of December 2025 (TTM) for NervGen Pharma Corp. (NGENF) is 442.70M

According to NervGen Pharma Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 442.70M. This represents a change of 126.33% compared to the average of 195.60M of the last 4 quarters.

NervGen Pharma Corp. (NGENF) Historical Enterprise Value (quarterly & annually)

How has NGENF Enterprise Value performed in the past?

The mean historical Enterprise Value of NervGen Pharma Corp. over the last ten years is 87.51M. The current 442.70M Enterprise Value has changed 50.49% with respect to the historical average. Over the past ten years (40 quarters), NGENF's Enterprise Value was at its highest in in the June 2025 quarter at 231.91M. The Enterprise Value was at its lowest in in the March 2018 quarter at 0.

NervGen Pharma Corp. (NGENF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of NervGen Pharma Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NervGen Pharma Corp. (NGENF) Average Enterprise Value

How has NGENF Enterprise Value performed in the past?

The current Enterprise Value of NervGen Pharma Corp. (NGENF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

NervGen Pharma Corp. (NGENF) Enterprise Value vs. Peers

How is NGENF’s Enterprise Value compared to its peers?

NervGen Pharma Corp.’s Enterprise Value is less than JW (Cayman) Therapeutics Co. Ltd (886.64M), greater than Brii Biosciences Limited (-453311803.63), greater than Genfit S.A. (262.96M), greater than Scancell Holdings plc (104.92M), greater than Molecular Partners AG (46.65M), greater than NDT Pharmaceuticals Inc. (158.40M), greater than Botanix Pharmaceuticals Limited (172.49M), greater than Innate Pharma S.A. (127.45M), greater than Santhera Pharmaceuticals Holding AG (215.74M), less than BICO Group AB (publ) (2.18B),

Build a custom stock screener for NervGen Pharma Corp. (NGENF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NervGen Pharma Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NervGen Pharma Corp. (NGENF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NervGen Pharma Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.